Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models | PLOS ONE
![1333489-03-4 | Regorafenib (Pyridine)-N-oxide-d3 | 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide-d3 | C21H12D3ClF4N4O4 | TRC 1333489-03-4 | Regorafenib (Pyridine)-N-oxide-d3 | 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide-d3 | C21H12D3ClF4N4O4 | TRC](https://www.trc-canada.com/prod-img/R143317.png)
1333489-03-4 | Regorafenib (Pyridine)-N-oxide-d3 | 4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-2-pyridinecarboxamide 1-Oxide-d3 | C21H12D3ClF4N4O4 | TRC
![35367-38-5 | Diflubenzuron | N-[[(4-Chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide; 1-(4-Chlorophenyl)-3-(2,6-difluorobenzoyl)urea; AI 3-29054; Diflubenzuron; Difluron; Dimilin; Dimilin 25; Du-Dim; Duphar PH 60-40; Larvakil; Micromite; Micromite ... 35367-38-5 | Diflubenzuron | N-[[(4-Chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide; 1-(4-Chlorophenyl)-3-(2,6-difluorobenzoyl)urea; AI 3-29054; Diflubenzuron; Difluron; Dimilin; Dimilin 25; Du-Dim; Duphar PH 60-40; Larvakil; Micromite; Micromite ...](https://www.trc-canada.com/prod-img/D445520.png)
35367-38-5 | Diflubenzuron | N-[[(4-Chlorophenyl)amino]carbonyl]-2,6-difluorobenzamide; 1-(4-Chlorophenyl)-3-(2,6-difluorobenzoyl)urea; AI 3-29054; Diflubenzuron; Difluron; Dimilin; Dimilin 25; Du-Dim; Duphar PH 60-40; Larvakil; Micromite; Micromite ...
Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study | PLOS ONE
![4-Acridinecarboxylic acid,9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]-6-methyl-,4-nitrophenyl ester, monohydrochloride 86611-50-9 wiki 4-Acridinecarboxylic acid,9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]-6-methyl-,4-nitrophenyl ester, monohydrochloride 86611-50-9 wiki](https://structimg.guidechem.com/4/52/1073991.png)
4-Acridinecarboxylic acid,9-[[2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino]-6-methyl-,4-nitrophenyl ester, monohydrochloride 86611-50-9 wiki
![Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy: Molecular Therapy - Oncolytics Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/479ffffe-e366-4b88-9b3d-f113f6cd6977/fx1_lrg.jpg)